GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.830
-0.060 (-3.17%)
Nov 11, 2026, 4:00 PM EST - Market closed
GRI Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.95 | 8.23 | 5.03 | 1.81 | 0.01 | 0.09 |
Cash & Short-Term Investments | 10.95 | 8.23 | 5.03 | 1.81 | 0.01 | 0.09 |
Cash Growth | 113.73% | 63.66% | 178.10% | 19988.89% | -90.00% | -73.29% |
Prepaid Expenses | 0.39 | 0.36 | 0.59 | 1.13 | 0.3 | 0.01 |
Total Current Assets | 11.33 | 8.59 | 5.62 | 2.93 | 0.31 | 0.1 |
Property, Plant & Equipment | 0.05 | 0.07 | 0.12 | 0.02 | 0.07 | 0.12 |
Other Long-Term Assets | - | - | - | - | - | 0.01 |
Total Assets | 11.38 | 8.67 | 5.74 | 2.96 | 0.38 | 0.22 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.53 | 1.84 | 0.9 | 1.41 | 1.29 | 0.06 |
Accrued Expenses | 0.53 | 0.75 | 0.69 | 1.27 | 0.04 | 1.27 |
Short-Term Debt | - | - | - | - | 0.6 | 3.5 |
Current Portion of Leases | 0.04 | 0.06 | 0.05 | 0.01 | 0.06 | 0.05 |
Other Current Liabilities | - | - | - | 0 | 0.01 | - |
Total Current Liabilities | 1.1 | 2.64 | 1.64 | 2.7 | 1.99 | 4.88 |
Long-Term Leases | - | 0.02 | 0.07 | - | 0.01 | 0.07 |
Other Long-Term Liabilities | - | - | - | - | - | 0.12 |
Total Liabilities | 1.1 | 2.66 | 1.71 | 2.7 | 2.01 | 5.07 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | - | - | 0.23 |
Additional Paid-In Capital | 65.62 | 57.7 | 43.77 | 31.79 | 16.87 | 10.2 |
Retained Earnings | -55.34 | -51.7 | -39.74 | -31.53 | -18.5 | -15.28 |
Shareholders' Equity | 10.28 | 6.01 | 4.03 | 0.26 | -1.63 | -4.85 |
Total Liabilities & Equity | 11.38 | 8.67 | 5.74 | 2.96 | 0.38 | 0.22 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.04 | 0.07 | 0.12 | 0.01 | 0.67 | 3.61 |
Net Cash (Debt) | 10.9 | 8.16 | 4.91 | 1.79 | -0.66 | -3.52 |
Net Cash Growth | 116.93% | 66.19% | 173.63% | - | - | - |
Net Cash Per Share | 13.04 | 83.11 | - | - | - | - |
Filing Date Shares Outstanding | 2.19 | 1.45 | 0.02 | - | 26.73 | 22.77 |
Total Common Shares Outstanding | 2.19 | 0.5 | 0.02 | - | 26.73 | 22.77 |
Working Capital | 10.23 | 5.95 | 3.98 | 0.24 | -1.68 | -4.78 |
Book Value Per Share | 4.70 | 12.07 | 214.85 | - | -0.06 | -0.21 |
Tangible Book Value | 10.28 | 6.01 | 4.03 | 0.26 | -1.63 | -4.85 |
Tangible Book Value Per Share | 4.70 | 12.07 | 214.85 | - | -0.06 | -0.21 |
Machinery | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 |